After almost two decades of the clinical use of GLP-1 for T2D and 10 years after the first GLP-1 medicine, liraglutide, was approved for #weight loss in people with obesity, the next decade may bring even greater progress, introducing more powerful GLP-1 medicines while expanding the utility of GLP-1 therapeutics beyond currently established #cardiometabolic disorders #GLP #obesity #publichealth #medicines #pharmacology Jean-Michel Dogns Post The benefits of GLP-1 drugs beyond obesity Excellent review on the Glucagon-like peptide1based medicines #diabetes and weight lossindependent actions
Measure or monitor functions of the body e.g
Long-term elevations in cortisol levels negatively affect gut microbiota function, by changing its composition and increasing gastrointestinal permeability
Why would I be prescribed metformin and Ozempic
The glucagon receptor arm the feature that distinguishes retatrutide from earlier-generation incretin compounds drives hepatic glucose metabolism, lipid oxidation, and energy expenditure effects, all absent from GLP-1 mono-agonists and dual GLP-1/GIP agonists
Chicory inulin adds an extra layer of ingredients to this GLP one formula